cancercompass.newgenes.org Reviews
is cancercompass.newgenes.org legitimate or a scam?How much trust do people have in cancercompass.newgenes.org?
Why is the trust score of cancercompass.newgenes.org low?
The website's database and tools are designed to offer a statistical approach to identifying pathways (gene sets) associated with cancer. It mentions the integration of data from multiple prominent databases to compile a comprehensive list of cancer genes and immune genes. This approach aims to ensure inclusivity and sound evidence by requiring multiple agreements between databases for gene inclusion.
The site also describes the process of pathway analysis, which involves over-representation analysis based on a hypergeometric test with false discovery rate (FDR) control through an extensive permutation test. This method is used to assess the enrichment of user-defined gene sets in biological pathways and prioritize pathways based on their likelihood of being associated with cancer.
The website's emphasis on a systematic and evidence-based approach, as well as its integration of data from multiple sources, suggests a commitment to rigorous scientific methodology. However, as with any scientific resource, it's important for researchers to critically evaluate the data and methodology presented on the site and consider additional sources of information and verification.
Overall, Cancer Compass appears to be a valuable resource for researchers in the field of cancer biology and genetics, providing a platform for accessing and analyzing data related to cancer genes, immune genes, and signaling pathways. Its focus on systematic analysis and integration of diverse data sources aligns with best practices in scientific research, but users should exercise critical thinking and verification in their use of the site's resources."
the reasons behind this review :
Cancer Compass is a website that provides a database and analytical tools for cancer research. It focuses on the systematic prioritization of signaling pathways, consensus cancer genes, consensus immune genes, and cancer pathways. The site aims to assist researchers in identifying and understanding the biological processes and genetic factors associated with cancer development and progression. The content emphasizes the importance of analyzing dysregulated signaling pathways, which play a critical role in processes like cell growth, differentiation, and death. Dysregulation of these pathways is often linked to cancer.
The website's database and tools are designed to offer a statistical approach to identifying pathways (gene sets) associated with cancer. It mentions the integration of data from multiple prominent databases to compile a comprehensive list of cancer genes and immune genes. This approach aims to ensure inclusivity and sound evidence by requiring multiple agreements between databases for gene inclusion.
The site also describes the process of pathway analysis, which involves over-representation analysis based on a hypergeometric test with false discovery rate (FDR) control through an extensive permutation test. This method is used to assess the enrichment of user-defined gene sets in biological pathways and prioritize pathways based on their likelihood of being associated with cancer.
The website's emphasis on a systematic and evidence-based approach, as well as its integration of data from multiple sources, suggests a commitment to rigorous scientific methodology. However, as with any scientific resource, it's important for researchers to critically evaluate the data and methodology presented on the site and consider additional sources of information and verification.
Overall, Cancer Compass appears to be a valuable resource for researchers in the field of cancer biology and genetics, providing a platform for accessing and analyzing data related to cancer genes, immune genes, and signaling pathways. Its focus on systematic analysis and integration of diverse data sources aligns with best practices in scientific research, but users should exercise critical thinking and verification in their use of the site's resources.
Positive Points | Negative Points |
---|---|
Website content is accessible No spelling or grammatical errors in site content High review rate by AI | Whois data is hidden |
Domain age :
unknow
WHOIS Data Status :
Hidden
Title :
Cancer Compass
Website Rank :
N/A
SSL certificate valid :
Valid
SSL Status :
Low - Domain Validated Certificates (DV SSL)
SSL issuer :
Amazon
IP : 52.84.125.19
ISP : AS16509 Amazon.com, Inc.
Country : US
IP : 52.84.125.41
ISP : AS16509 Amazon.com, Inc.
Country : US
IP : 52.84.125.72
ISP : AS16509 Amazon.com, Inc.
Country : US
IP : 52.84.125.3
ISP : AS16509 Amazon.com, Inc.
Country : US
Target : ns-454.awsdns-56.com
IP : 205.251.193.198
ISP : AS16509 Amazon.com, Inc.
Country : US
Target : ns-1287.awsdns-32.org
IP : 205.251.197.7
ISP : AS16509 Amazon.com, Inc.
Country : US
Target : ns-742.awsdns-28.net
IP : 205.251.194.230
ISP : AS16509 Amazon.com, Inc.
Country : US
Target : ns-1898.awsdns-45.co.uk
IP : 205.251.199.106
ISP : AS16509 Amazon.com, Inc.
Country : US
This website was last scanned on August 23, 2024
jiffy.com
https://jiffy.com redirected to https//www.jiffy.com during the time we crawled it. Jiffy.com is a well-established e-commerce platform specializing in wholesale apparel. The website offers a wide range of clothing items, including...
cam.ac.uk
https://cam.ac.uk redirected to https//www.cam.ac.uk during the time we crawled it. The University of Cambridge is a prestigious and well-established institution with a long history of academic excellence. It is one...
parkinggbz.top
https://parkinggbz.top redirected to https//stockx.com during the time we crawled it. The website's URL is https://stockx.com/. The website's content was intentionally made inaccessible, suggesting that the site owner may have content...